IL129618A0 - Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes - Google Patents

Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Info

Publication number
IL129618A0
IL129618A0 IL12961897A IL12961897A IL129618A0 IL 129618 A0 IL129618 A0 IL 129618A0 IL 12961897 A IL12961897 A IL 12961897A IL 12961897 A IL12961897 A IL 12961897A IL 129618 A0 IL129618 A0 IL 129618A0
Authority
IL
Israel
Prior art keywords
syndromes
prevention
treatment
related diseases
derivatives useful
Prior art date
Application number
IL12961897A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL129618A0 publication Critical patent/IL129618A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL12961897A 1996-10-28 1997-10-28 Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes IL129618A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK119996 1996-10-28
PCT/DK1997/000485 WO1998018778A1 (en) 1996-10-28 1997-10-28 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (1)

Publication Number Publication Date
IL129618A0 true IL129618A0 (en) 2000-02-29

Family

ID=8102089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12961897A IL129618A0 (en) 1996-10-28 1997-10-28 Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Country Status (8)

Country Link
EP (1) EP0934299A1 (no)
JP (1) JP2001502710A (no)
AU (1) AU4772297A (no)
CA (1) CA2270056A1 (no)
IL (1) IL129618A0 (no)
NO (1) NO992005L (no)
WO (1) WO1998018778A1 (no)
ZA (1) ZA979649B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE225782T1 (de) * 1996-12-13 2002-10-15 Chugai Pharmaceutical Co Ltd Benzopyranderivate
JP2000119187A (ja) * 1998-10-15 2000-04-25 Taisho Pharmaceut Co Ltd 抑うつ気分の予防または改善用組成物
CN101056868B (zh) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
WO2012061409A1 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
PT3253208T (pt) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Terapêuticas de combinação para utilização no tratamento do cancro da mama
CN115003295B (zh) * 2019-12-12 2025-05-06 冰洲石生物科技公司 具有雌激素受体降解活性的新型色满衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
WO1998018778A1 (en) 1998-05-07
ZA979649B (en) 1998-04-28
NO992005L (no) 1999-06-25
CA2270056A1 (en) 1998-05-07
EP0934299A1 (en) 1999-08-11
JP2001502710A (ja) 2001-02-27
AU4772297A (en) 1998-05-22
NO992005D0 (no) 1999-04-27

Similar Documents

Publication Publication Date Title
AP9701077A0 (en) Substituted 6,5-hetero bicyclic derivatives
AP9701076A0 (en) Substituted 6,6-hetero bicyclic derivatives
ZA952413B (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
ZA964298B (en) Use of aryl-substituted cyclobutylalkylamines for the treatment of obesity.
ZA9710322B (en) Process for the preparation of benzyl-ethers.
ZA979731B (en) Treatment of asthma.
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL129622A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA978359B (en) Novel treatment
IL129623A0 (en) Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU2173597A (en) Process for the preparation of tenidap
IL129624A0 (en) Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129626A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
GB9615767D0 (en) Novel treatment
IL129617A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
GB9608657D0 (en) Novel treatment
GB9625795D0 (en) Novel treatment
GB9612752D0 (en) Novel treatment
ZA9610708B (en) Oxaindene derivatives and process for the preparation thereof.
ZA984822B (en) Pyrrolo (2,11,5-cd) indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA984823B (en) Pyrrolo(2,1,5-cd)indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU7539596A (en) Oxaindene derivatives and process for the preparation thereof
CA78940S (en) Pasta